Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 3/2022

Content (21 Articles)

Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study

Francesco Franchi, David J. Schneider, Jayne Prats, Weihong Fan, Fabiana Rollini, Latonya Been, Heidi S. Taatjes-Sommer, Deepak L. Bhatt, Efthymios N. Deliargyris, Dominick J. Angiolillo

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes

Angelo Silverio, Francesco Paolo Cancro, Marco Di Maio, Michele Bellino, Luca Esposito, Mario Centore, Albino Carrizzo, Paola Di Pietro, Anna Borrelli, Giuseppe De Luca, Carmine Vecchione, Gennaro Galasso

Serial assessment of thrombogenicity and hemodynamics in patients with type II diabetes in a clinical research unit: Evidence for circadian variations in clot formation

Rahul Chaudhary, Tushar Sharma, Udaya S. Tantry, Juzer Ali Asgar, Parshotam Kundan, Sanchit Duhan, Haroon Gill, Arvind Singh, Yazan Alasadi, Paul A. Gurbel, Kevin P. Bliden

Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism

Martin R. Prince, Hreedi Dev, Elizabeth G. Lane, Daniel J. Margolis, Maria T. DeSancho

Open Access Obesity

Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States

Jeffrey S. Berger, François Laliberté, Akshay Kharat, Dominique Lejeune, Kenneth Todd Moore, Young Jung, Patrick Lefebvre, Veronica Ashton

Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team

Romain Chopard, Umberto Campia, Lucas Morin, Karola S. Jering, Zaid I. Almarzooq, Julia Elizabeth Snyder, Samantha Rizzo, Aaron B. Waxman, Samuel Z. Goldhaber, Gregory Piazza

Open Access Warfarin

Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding

Alan S. Go, Thomas K. Leong, Sue Hee Sung, Rong Wei, Teresa N. Harrison, Nigel Gupta, Nicole Baker, Brahm Goldstein, Quazi Ataher, Matthew D. Solomon, Kristi Reynolds

Popliteal cysts are not a risk factor for lower extremity deep vein thrombosis

Paul Daniels, Danielle Vlazny, Ryan Meverden, Matthew Bartlett, Gina Hesley, Alexander Lekah, Thanila Macedo, Waldemar E. Wysokinski, Damon E. Houghton

Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry

Yugo Yamashita, Takeshi Morimoto, Frederikus A. Klok, Stefano Barco, Yuji Nishimoto, Takao Kato, Koh Ono, Takeshi Kimura

Favourable collaterals according to the Careggi Collateral Score grading system in patients treated with thrombectomy for stroke with middle cerebral artery occlusion

Manuel Cappellari, Giulia Sajeva, Raffaele Augelli, Cecilia Zivelonghi, Mauro Plebani, Nicolò Mandruzzato, Salvatore Mangiafico

Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry

Dapeng Sun, Xiaochuan Huo, Raynald, Baixue Jia, Xu Tong, Gaoting Ma, Anxin Wang, Ning Ma, Feng Gao, Dapeng Mo, Zhongrong Miao

Correction to: Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension

Lifan Yang, Lei Zhang, Shasha Chen, Mingfei Li, Yuliang Long, Wei Li, Qi Jin, Lihua Guan, Daxin Zhou, Junbo Ge

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.